- The folks at City of Hope Medical Center are studying the effects of positron emission tomography; copper Cu 64-DOTA-trastuzumab; Biopsy; Immunohistochemistry staining method; laboratory biomarker analysis; mutation analysis on Breast Cancer and Stage IV Breast Cancer in females ages 18 years and older. This clinical trial is slated to start March 2011.
This study is officially titled, "64 Cu-DOTA-Trastuzumab Positron Emission Tomography in Women With Advanced HER2 Positive Invasive Breast Cancer."
|Recruiting||City of Hope|
Duarte, California, 91010
United States - map
|Joanne E. Mortimer||800-826-4673|
For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.